Vitamin B12 does affect blood sugar, though not as directly as insulin or carbohydrate intake. The connection runs primarily through B12’s role in metabolic pathways that influence how your body handles insulin and processes glucose. When B12 levels drop too low, insulin resistance tends to worsen, and correcting the deficiency with supplements has been shown to improve markers of blood sugar control in people with type 2 diabetes. The relationship is more layered than a simple “low B12 equals high blood sugar,” and some of the findings are genuinely surprising.
How B12 Relates to Insulin Resistance
Insulin resistance is the condition where your cells stop responding efficiently to insulin, so glucose builds up in the blood instead of being absorbed. Several studies have found that low B12 levels are tied to higher insulin resistance, even in people who do not have diabetes. In a study of non-diabetic obese patients, insulin resistance was present in over half of participants, and lower B12 levels were associated with worse insulin resistance scores.1PubMed Central. Vitamin Deficiency and Insulin Resistance in Nondiabetic Obese Patients A separate study of people with severe obesity found a similar pattern: those with the lowest B12 levels and highest levels of methylmalonic acid (a metabolic byproduct that rises when B12 is scarce) had greater insulin resistance.2PubMed. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity
One biological explanation involves homocysteine, an amino acid that B12 helps convert into a harmless form. When B12 is deficient, homocysteine accumulates. In a clinical trial of people with metabolic syndrome, treating elevated homocysteine with folate and B12 lowered homocysteine by roughly 28%, and insulin levels dropped alongside it, with a corresponding reduction in insulin resistance of about 27%. The researchers found a direct positive correlation between the drop in homocysteine and the drop in insulin.3PubMed. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia This suggests that the homocysteine pathway is at least one mechanism through which B12 status influences how well your body uses insulin.
Another pathway involves fat metabolism in the liver. When B12 is low, the liver becomes less efficient at burning fatty acids, and fat accumulates in liver tissue. That lipid buildup is independently associated with insulin resistance.4University of Warwick Institutional Repository. The role of vitamin B12 deficiency on hepatic metabolism of lipids So B12 deficiency can worsen blood sugar control through at least two routes: elevated homocysteine and disrupted liver fat metabolism.
What Happens When People With Type 2 Diabetes Take B12
The more practical question for most readers is whether supplementing B12 actually moves the needle on blood sugar. The evidence here is cautiously encouraging, at least for people who are deficient. In a multi-arm randomized trial of people with type 2 diabetes, those who received B12 supplementation (alone or combined with folic acid) saw meaningful improvements in HbA1c, the standard measure of long-term blood sugar control. The group taking B12 plus folic acid saw a median HbA1c drop of about 1.5 percentage points, and the B12-only group dropped about 1.2 points. Both groups also showed improvements in insulin resistance and insulin levels compared to controls.5PubMed. Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
A more recent double-blind trial looked at adding methylcobalamin (a form of B12) on top of the diabetes drug dapagliflozin. Over 12 months, the group getting both B12 and the drug had lower HbA1c than the drug-only group, with the difference becoming apparent as early as three months and continuing to widen.6PubMed Central. Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers, Combined with Dapagliflozin as Type 2 Diabetes Mellitus Routine Treatment: A Controlled Randomized, Double-blind Trial The B12 group also had a modest reduction in body mass index compared to controls. These are encouraging results, but both trials involved people with existing diabetes and, in many cases, likely B12 deficiency. The evidence does not yet support the idea that extra B12 will improve blood sugar in someone whose B12 levels are already normal.
The Metformin Problem
If you take metformin for type 2 diabetes, the B12 question is especially relevant. Metformin is the most widely prescribed diabetes drug in the world, and it is well established that long-term use lowers B12 levels. The mechanism involves how metformin interferes with calcium-dependent absorption of B12 in the small intestine. Longer treatment and higher doses are associated with a greater likelihood of developing outright B12 deficiency.7PubMed Central. Vitamin B12 deficiency in diabetic patients treated with metformin: A narrative review
This creates a frustrating cycle. You take metformin to control blood sugar, but metformin gradually depletes the B12 your body needs for efficient insulin signaling and glucose metabolism. The depletion can take years to become clinically obvious, and many people on long-term metformin are never routinely screened for B12. In practice, this means that some fraction of worsening blood sugar control in metformin users could be partly caused by B12 deficiency rather than disease progression. If you have been on metformin for several years and your blood sugar numbers have been creeping upward, it is worth asking your doctor to check your B12 level.
When Low B12 Makes Your Blood Sugar Look Worse Than It Is
Here is a wrinkle that catches many people and even some clinicians off guard. B12 deficiency can artificially inflate your HbA1c reading, the test used to diagnose and monitor diabetes. HbA1c measures glycated hemoglobin in red blood cells. When B12 is very low, red blood cells become larger and live longer than normal, giving glucose more time to attach to the hemoglobin. The result is an HbA1c reading that looks higher than your actual average blood sugar warrants.
A study of patients with B12 deficiency anemia found that after three months of B12 treatment, hemoglobin levels rose (as expected when correcting anemia), and HbA1c dropped by an average of 0.24 percentage points. Before treatment, some of these patients had HbA1c values in the prediabetes range. After correcting their B12 deficiency alone, about 35% of them no longer met the threshold for a prediabetes diagnosis.8PubMed Central. Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia This is a genuinely important finding. It means that some people walking around with a “prediabetes” label might not actually have a blood sugar problem at all; they have a B12 problem masquerading as one. If your HbA1c is borderline and you have any risk factors for B12 deficiency, including vegetarian or vegan diets, long-term metformin use, or digestive conditions, a B12 test before accepting a prediabetes diagnosis is a reasonable step.
B12 and Gestational Diabetes
The relationship between B12 and blood sugar takes on added significance during pregnancy. Several studies have linked lower maternal B12 levels in early pregnancy to a higher risk of gestational diabetes, the form of diabetes that develops during pregnancy and typically resolves after delivery. A prospective UK study found that higher B12 levels in early pregnancy were associated with roughly 14% lower risk of gestational diabetes after adjusting for age, smoking, ethnicity, family history, and income. Higher B12 was also tied to lower fasting glucose and lower two-hour glucose levels on an oral glucose tolerance test. About half of B12’s protective association was explained by its link to lower BMI.9PubMed Central. Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study)
The combination of high folate and low B12 appears to be the most problematic scenario. When folate is abundant but B12 is scarce, certain metabolic conversions stall, and methylmalonic acid accumulates. That buildup has been linked to increased insulin resistance, which is thought to contribute to gestational diabetes risk.10PubMed Central. The Relationship Between Folate, Vitamin B12 and Gestational Diabetes Mellitus With Proposed Mechanisms and Foetal Implications This matters because many women take folic acid supplements before and during pregnancy (rightly so, for neural tube defect prevention) without paying attention to B12. The research suggests that folate supplementation without adequate B12 could inadvertently raise blood sugar risk in susceptible individuals.
One cohort study did report a slightly different angle, finding that higher B12 was associated with increased gestational diabetes risk per 100 pg/mL increase.11Diabetes Care. Association of Maternal Folate and Vitamin B12 in Early Pregnancy With Gestational Diabetes Mellitus: A Prospective Cohort Study This highlights that the relationship is not perfectly straightforward and may depend on the population studied, how B12 is measured, and the balance with folate. The weight of the evidence points toward B12 deficiency being the bigger concern in pregnancy, but the picture is not fully settled.
The Paradox of High B12 Levels
One of the more counterintuitive findings in this area is that unusually high B12 levels in the blood are also associated with diabetes and poor metabolic health. People with type 2 diabetes who did not use metformin had significantly higher serum B12 levels than those without diabetes, and this held true even after excluding metformin users from the analysis.12Journal of the Endocrine Society. Elevated Serum B12 Levels are Associated with Diabetes Another study found that among people with type 2 diabetes, those with wider blood sugar swings throughout the day had higher B12 levels, and B12 was independently correlated with greater glycemic variability regardless of whether the person was taking metformin.13PubMed Central. Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus
This does not mean that taking B12 supplements causes diabetes. High serum B12 is often a marker of something else going on in the body, such as liver disease, inflammation, or altered B12 transport proteins, rather than a reflection of excessive B12 intake. Some researchers have noted that elevated B12 may predict higher mortality risk in elderly patients and could signal kidney or liver problems.14PubMed Central. Vitamin B12 and risk of diabetes: new insight from cross-sectional and longitudinal analyses of the China Stroke Primary Prevention Trial (CSPPT) The takeaway is not to fear B12 supplementation but to understand that if a blood test shows your B12 is unusually high without supplementation, that finding deserves investigation rather than reassurance.
Diabetic Neuropathy and B12 Supplementation
Even if B12’s direct effect on blood sugar numbers were modest, its role in diabetic neuropathy makes it critical for anyone with diabetes. Diabetic neuropathy is nerve damage caused by prolonged high blood sugar, producing symptoms like tingling, numbness, and pain in the hands and feet. B12 is essential for maintaining the myelin sheath that insulates nerve fibers, so deficiency compounds the nerve damage that high blood sugar is already causing.
A meta-analysis of randomized controlled trials found that patients receiving B12 supplementation had greater reductions in neuropathic symptoms and pain scores compared to controls. The effect on pain was large enough to be clinically meaningful.15PubMed Central. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials This finding is especially relevant for metformin users, who face a double hit: the drug that controls their blood sugar also depletes the vitamin that protects their nerves. The neuropathy connection is one of the strongest practical reasons to monitor B12 in anyone with diabetes, even if the blood sugar effects alone do not seem dramatic.
Type 1 Diabetes and Autoimmune B12 Deficiency
The B12 story looks different in type 1 diabetes, where the concern is less about insulin resistance and more about autoimmune overlap. Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing cells. People with one autoimmune condition are at higher risk for others, and pernicious anemia, a condition where the immune system attacks the stomach cells needed to absorb B12, is one of the more common companions to type 1 diabetes. Estimates place its prevalence at roughly 2.6% to 4% in people with type 1 diabetes, compared to less than 1% in the general population.16PubMed. Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease When autoimmune thyroid disease is also present, one study found the prevalence of pernicious anemia reached about 6%.16PubMed. Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease
For people with type 1 diabetes, B12 deficiency from pernicious anemia can cause severe neurological symptoms that mimic or overlap with diabetic complications, potentially delaying correct diagnosis. Screening for B12 deficiency in anyone with type 1 diabetes, particularly if they also have thyroid disease, is a straightforward step that can prevent significant harm.
What Animal Research Suggests About B12 and Pancreatic Cells
Laboratory studies have hinted at another mechanism by which B12 could influence blood sugar. In cell and animal experiments, B12 appeared to protect insulin-producing beta cells from oxidative stress and programmed cell death. When beta cells were exposed to a toxin that mimics the kind of damage seen in diabetes, B12 treatment reduced both oxidative injury and cell death by activating a protective signaling pathway.17Journal of Biomaterials and Tissue Engineering. Vitamin B12 Inhibits Streptozotocin-Induced Islet β-Cell Oxidative Stress and Apoptosis by Activating Peroxisome Proliferator-Activated Receptor-γ Signaling Pathway This is intriguing but firmly in the early-research category. Protecting cells in a dish or in rodents does not guarantee the same effect in humans, and no clinical trials have yet tested whether B12 supplementation preserves beta-cell function in people at risk for diabetes.
Separately, animal research on maternal B12 deficiency found that rat pups born to B12-deficient mothers had lower birth weight, more body fat, and greater insulin resistance. The researchers traced these effects to changes in DNA methylation patterns in genes related to fat metabolism, and restoring B12 during pregnancy partially reversed those changes.18PubMed Central. Maternal vitamin B12 deficiency in rats alters DNA methylation in metabolically important genes in their offspring If this translates to humans, it would suggest that maternal B12 status during pregnancy could program a child’s metabolic health before birth. This aligns with the gestational diabetes findings discussed earlier and adds another layer of urgency to ensuring adequate B12 in pregnancy.
Genetics That Change How B12 Works in Your Body
Not everyone processes B12 the same way, even at the same blood level. Genetic variants in the proteins that transport B12 can alter how effectively it reaches the tissues where it is needed. One such variant in the transcobalamin gene was associated with over three-fold higher odds of peripheral neuropathy in elderly individuals. When those same people also had high folate intake (more than twice the recommended amount), the odds of neuropathy jumped to roughly seven-fold higher for the most affected genotype.19The American Journal of Clinical Nutrition. Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake
This finding has two practical implications. First, your serum B12 level on a blood test might look adequate while your cells are actually starved of it because the transport system is genetically less efficient. Second, the interaction with folate echoes the pattern seen in gestational diabetes research: high folate combined with functionally low B12 appears to worsen outcomes. For anyone with diabetes-related neuropathy that does not improve with standard treatment, or anyone whose B12 levels are “normal” but who still has symptoms of deficiency, a genetic component may be worth considering.
Who Should Be Paying Attention
Certain groups face a heightened risk of B12 deficiency and are also disproportionately affected by blood sugar problems. People on long-term metformin, as already discussed, are at the top of the list. Older adults absorb B12 less efficiently due to declining stomach acid production. People who follow plant-based diets get little to no B12 from food, since the vitamin is found almost exclusively in animal products. Anyone with digestive conditions affecting the stomach or small intestine, including celiac disease, Crohn’s disease, or a history of gastric surgery, may absorb B12 poorly regardless of dietary intake.
For these groups, a B12 blood test is inexpensive and widely available. If deficiency is confirmed, supplementation is safe, affordable, and in many cases will improve both nerve health and metabolic function. The research does not yet support taking high-dose B12 as a blood sugar treatment in people with normal levels. But for the substantial number of people who are quietly deficient without realizing it, correcting that deficiency may be one of the simplest interventions available for improving metabolic health.